Zheng et al. demonstrated that CD4+ T cells with low levels of IFN‐γ, IL‐2 and TNF‐α were higher in severe COVID‐19 patients, compared with healthy controls and mild patients.90 This evidence concerns the gene IFNG and COVID-19.